Tang MS - Search Results

1

Oncogenic HRAS Activates Epithelial-to-Mesenchymal Transition and Confers Stemness to p53-Deficient Urothelial Cells to Drive Muscle Invasion of Basal Subtype Carcinomas.

He F, Melamed J, Tang MS, Huang C, Wu XR. He F, et al. Among authors: tang ms. Cancer Res. 2015 May 15;75(10):2017-28. doi: 10.1158/0008-5472.CAN-14-3067. Epub 2015 Mar 20. Cancer Res. 2015. PMID: 25795707 Free PMC article.

2

FGFR3b Extracellular Loop Mutation Lacks Tumorigenicity In Vivo but Collaborates with p53/pRB Deficiency to Induce High-grade Papillary Urothelial Carcinoma.

Zhou H, He F, Mendelsohn CL, Tang MS, Huang C, Wu XR. Zhou H, et al. Among authors: tang ms. Sci Rep. 2016 May 9;6:25596. doi: 10.1038/srep25596. Sci Rep. 2016. PMID: 27157475 Free PMC article.

3

PKM2 Is Essential for Bladder Cancer Growth and Maintenance.

Xia Y, Wang X, Liu Y, Shapiro E, Lepor H, Tang MS, Sun TT, Wu XR. Xia Y, et al. Among authors: tang ms. Cancer Res. 2022 Feb 15;82(4):571-585. doi: 10.1158/0008-5472.CAN-21-0403. Cancer Res. 2022. PMID: 34903602 Free PMC article.

4

Structural or functional defects of PTEN in urothelial cells lacking P53 drive basal/squamous-subtype muscle-invasive bladder cancer.

He F, Zhang F, Liao Y, Tang MS, Wu XR. He F, et al. Among authors: tang ms. Cancer Lett. 2022 Dec 1;550:215924. doi: 10.1016/j.canlet.2022.215924. Epub 2022 Oct 3. Cancer Lett. 2022. PMID: 36195293 Free PMC article.

5

Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies.

Zhou H, Huang HY, Shapiro E, Lepor H, Huang WC, Mohammadi M, Mohr I, Tang MS, Huang C, Wu XR. Zhou H, et al. Among authors: tang ms. Carcinogenesis. 2012 Apr;33(4):770-80. doi: 10.1093/carcin/bgs025. Epub 2012 Jan 27. Carcinogenesis. 2012. PMID: 22287562 Free PMC article.

6

XIAP RING domain mediates miR-4295 expression and subsequently inhibiting p63α protein translation and promoting transformation of bladder epithelial cells.

Jin H, Xu J, Guo X, Huang H, Li J, Peng M, Zhu J, Tian Z, Wu XR, Tang MS, Huang C. Jin H, et al. Among authors: tang ms. Oncotarget. 2016 Aug 30;7(35):56540-56557. doi: 10.18632/oncotarget.10645. Oncotarget. 2016. PMID: 27447744 Free PMC article.

7

Dominant role of CDKN2B/p15INK4B of 9p21.3 tumor suppressor hub in inhibition of cell-cycle and glycolysis.

Xia Y, Liu Y, Yang C, Simeone DM, Sun TT, DeGraff DJ, Tang MS, Zhang Y, Wu XR. Xia Y, et al. Among authors: tang ms. Nat Commun. 2021 Apr 6;12(1):2047. doi: 10.1038/s41467-021-22327-5. Nat Commun. 2021. PMID: 33824349 Free PMC article.

8

The role of TAp63γ and P53 point mutations in regulating DNA repair, mutational susceptibility and invasion of bladder cancer cells.

Wang HT, Lee HW, Weng MW, Liu Y, Huang WC, Lepor H, Wu XR, Tang MS. Wang HT, et al. Among authors: tang ms. Elife. 2021 Nov 8;10:e71184. doi: 10.7554/eLife.71184. Elife. 2021. PMID: 34747697 Free PMC article.

9

Inhibition of benzo(a)pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor kappaB by black raspberry extracts.

Huang C, Huang Y, Li J, Hu W, Aziz R, Tang MS, Sun N, Cassady J, Stoner GD. Huang C, et al. Among authors: tang ms. Cancer Res. 2002 Dec 1;62(23):6857-63. Cancer Res. 2002. PMID: 12460899

10

Acrolein- and 4-Aminobiphenyl-DNA adducts in human bladder mucosa and tumor tissue and their mutagenicity in human urothelial cells.

Lee HW, Wang HT, Weng MW, Hu Y, Chen WS, Chou D, Liu Y, Donin N, Huang WC, Lepor H, Wu XR, Wang H, Beland FA, Tang MS. Lee HW, et al. Among authors: tang ms. Oncotarget. 2014 Jun 15;5(11):3526-40. doi: 10.18632/oncotarget.1954. Oncotarget. 2014. PMID: 24939871 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters